The store will not work correctly when cookies are disabled.
N,N-dimethyl-1-(4-(5-methyl-1,3-oxazol-2-yl)pyridin-3-yl)piperidine-4-carboxamide
ID: ALA4546861
PubChem CID: 118450781
Max Phase: Preclinical
Molecular Formula: C17H22N4O2
Molecular Weight: 314.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cnc(-c2ccncc2N2CCC(C(=O)N(C)C)CC2)o1
Standard InChI: InChI=1S/C17H22N4O2/c1-12-10-19-16(23-12)14-4-7-18-11-15(14)21-8-5-13(6-9-21)17(22)20(2)3/h4,7,10-11,13H,5-6,8-9H2,1-3H3
Standard InChI Key: NRVUXFJRRGZAMD-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
10.6581 -8.1579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9482 -7.7493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9482 -6.9280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6581 -6.5194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3680 -6.9280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3680 -7.7493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6581 -5.6981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3680 -5.2895 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9482 -5.2895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2384 -5.6981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9482 -4.4682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6581 -8.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9482 -9.3878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9482 -10.2091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6581 -10.6177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3680 -10.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3680 -9.3878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0779 -8.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8167 -9.3053 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3656 -8.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9529 -7.9970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1604 -8.1579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1828 -8.7894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
9 11 1 0
1 12 1 0
13 12 1 0
13 14 2 0
15 14 1 0
16 15 2 0
17 16 1 0
12 17 2 0
17 18 1 0
19 18 1 0
19 20 1 0
21 20 2 0
22 21 1 0
18 22 2 0
20 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.39 | Molecular Weight (Monoisotopic): 314.1743 | AlogP: 2.35 | #Rotatable Bonds: 3 |
Polar Surface Area: 62.47 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.49 | CX LogP: 0.74 | CX LogD: 0.74 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.87 | Np Likeness Score: -1.47 |
References
1. (2017) Heterocyclic compounds having cholesterol 24-hydroxylase activity, |